on Philippines stocks ** Company specific risk premium of 3.0% to 4.0% 5 Years of Financial assumptions Sales revenues  CCPH is projected to have annual revenue growth of 2-5% primarily in consider

. (1) Expand opportunity to enter into skincare, cosmeceuticals or cosmetics and medical business, which has positive growth trend and being one of government business enterprise support as Policy

and the Company’s shareholders as follows. (1) Expand opportunity to enter into skincare, cosmeceuticals or cosmetics and medical business, which has positive growth trend and being one of government

shareholders as follows. (1) Expand opportunity to enter into skincare, cosmeceuticals or cosmetics and medical business, which has positive growth trend and being one of government Ref. WINNER 0009/20108 Page 9

capital. The Company expects the following benefits: 1. To use for the investment in other main business expansion of the group of the company to the Organic and Sustained growth. 2. Could get a better

Discussion and Analysis 2019 Management Outlook The Company still concentrates on the strategy of managing the quality of Boonterm kiosk location with the ARPU management more than 5% growth and the total

is likely leaving its mark on the Thai economy. Private consumption growth moderated noticeably in Q1 while private investment fell, reflecting dampening domestic demand. Manufacturing output

excellence, global scale, differentiated formulations and technologies and fits into its growth segments of Integrated EOs and the Specialty Chemicals portfolio consisting of both Ethylene Oxide and Propylene

Growth: SSSG (%) (2) 9.4% -2.9% Growth of Revenue from Restaurant Business (%) 21.9% 0.7% Remark: (1) Outlets owned by the Group (2) Calculated based on total revenue from sales and service per total

activity in the first quarter of 2018 continued to expand from the previous quarter, driven mainly by the solid growth momentum of merchandise exports and the tourism sector. Private consumption continued to